Red Light Holland Corp. announced updates regarding its Research and Development program in collaboration with CCrest Laboratories Inc. ("CCrest Laboratories"), a Montreal-based cGMP pharmaceutical laboratory, that holds a Controlled Drugs and Substances Dealer's License. PharmAla was founded with a dual focus: alleviating the global backlog of generic, clinical-grade MDMA to enable clinical trials as well as commercial sales in selected jurisdictions, and to develop novel drugs in the same class.

PharmAla is the only company currently provisioning clinical-grade MDMA for patient treatments outside of clinical trials. Complete stability tests; the ability of the Government of Australia and/or NewZealand and/or Canada to down list psilocybe truffles under its controlled substances list and under the stated timelines; the Company's ability to continue developing its products for microdosing that can potentially be accessible in emerging legal markets worldwide; future plans; finalizing report, import permit; participating in clinical trials and/or Special Access Program; and the Company's ability to provide updates with respect to its continued work with its partners on the microdosing products.